Study to determine the relationship between intestinal FDG accumulation and obesity in non-diabetic patients

Study to determine the relationship between intestinal FDG accumulation and obesity in non-diabetic patients - Study to determine the relationship between intestinal FDG accumulation and obesity

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055445

Enrollment

130

Registered

2024-09-06

Start date

2023-02-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent 18F FDG PET MRI examination and whose details can be obtained from their medical records Patients who are 20 years of age or older Patients who have not been diagnosed as diabetic based on the information in the medical record Patients who are not receiving oral or injectable diabetes medication based on the information in the medical record Non diabetic patients whose body mass index (BMI) is between 18.5 and 25 (normal weight group) Non diabetic patients with body mass index (BMI) of 30 or more (obese group with body mass index of 2 or more)

Exclusion criteria

Exclusion criteria: (i) If 18F-FDG-PET/MRI examination has been performed multiple times, for the first imaging and for the third and subsequent imaging (ii) Those who have a record of HbA1c of 6.5% or higher from the medical record (iii) Patients with end-stage renal failure with eGFR less than 30 mL/min/1.73m2 from the medical record (iv) Patients whose intestine to be analyzed has been resected (v) Patients with incidental intestinal cancer other than the main disease in the intestinal tract to be analyzed (vi) Patients for whom 18FDG-PET/MRI images are judged to be inappropriate. (vii) Patients who have requested not to participate in this study based on the disclosed information. (viii) Patients whom the principal investigator determines to be inappropriate for this study

Design outcomes

Primary

Measure	Time frame
Visual evaluation of FDG accumulation	—

Secondary

Measure	Time frame
Comparison of patient background factors between the two groups Correlation between visual assessment of intestinal FDG accumulation and patient background factors Semi-quantitative evaluation of intestinal FDG accumulation	—

Countries

Japan

Contacts

Public ContactYasuko Morita

Kobe University Hospital Division of Diabetes and Endocrinology

kzhkskgc@med.kobe-u.ac.jp078-382-5861

Outcome results